Riskpilot← Back to searchSign inGet full accessCellKarl AB
ABActiveOrg 5567372015Conricusgatan 7Business and other management consultancy activities · NACE 7020Est. 20070 employees
Revenue 2024
SEK 0
EBITDA margin
—
-43% vs 2023
Equity ratio
97.2%
Financial strength
Net profit 2024
SEK 50M
+659% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,4M | -43% |
| Net profit | SEK 50M | +659% |
| Total assets | SEK 108,3M | +91% |
| Equity | SEK 105,3M | +87% |
| Employees | 0 | — |
Legal name
CellKarl AB
Org number
5567372015
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
7 september 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets verksamhet ska vara att äga och förvalta aktier och fast egendom samt därmed förenlig verksamhet.
Address
Conricusgatan 7
Email
testliner@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −88 |
| EBITDA | −369 | −601 | −760 | −1 004 | −1 435 |
| Depreciation & amort. | −50 | −50 | −50 | −50 | −91 |
| EBIT | −419 | −651 | −810 | −1 054 | −1 526 |
| Net financials | 29 588 | 29 583 | −4 594 | −7 898 | 51 518 |
| Profit before tax | 29 169 | 28 933 | −4 018 | −8 951 | 49 993 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 29 169 | 28 933 | −4 018 | −8 951 | 49 993 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 45 981 | 73 664 | 68 744 | 56 623 | 108 344 |
| Equity | 41 090 | 69 803 | 65 600 | 56 454 | 105 341 |
| Long-term debt | 2 707 | 2 511 | 2 408 | 0 | 2 617 |
| Short-term debt | 2 184 | 1 350 | 737 | 169 | 385 |
| Total debt | 4 891 | 3 861 | 3 145 | 169 | 3 003 |
EBITDA margin
-143481600.0%
This company
15.8%
Market median
-908111492% vs market
20202024
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20202024
Return on equity
47.5%
This company
18.4%
Market median
+158% vs market
20202024
Net profit margin
4999251800.0%
This company
8.1%
Market median
+61719157925% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CellKarl AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Henrik Ödman | Chief Executive Officer | 0 companies |
| Jenny Maria Hempel Ödman | Deputy Board Member | 0 companies |